Legis Daily

Terminate CDC Overreach Act

USA118th CongressHR-6305| House 
| Updated: 11/10/2023
Anna Paulina Luna

Anna Paulina Luna

Republican Representative

Florida

Cosponsors (3)
Elijah Crane (Republican)Harriet M. Hageman (Republican)Mary E. Miller (Republican)

Rules Committee, Health Subcommittee, Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Terminate CDC Overreach Act This bill narrows the authority of the Centers for Disease Control and Prevention (CDC) to create regulations on controlling the spread of disease. Under current law, the CDC is authorized to create regulations generally relating to quarantine and isolation to prevent the spread of disease between people. This includes regulations applicable to individuals traveling interstate that are reasonably believed to have a disease in a qualifying stage , meaning the disease is contagious or would likely cause a public health emergency if transmitted. The bill specifies that there must be a positive clinical test, rigorous contact tracing, or clinical presentation of the disease in order for individuals to be considered as having a disease in a qualifying stage for purposes of regulation. The bill also specifies that CDC regulations must relate to preventing the spread of disease between states through the identification, isolation, or destruction of the disease itself. The bill establishes procedures for Congress to expedite consideration of joint resolutions of disapproval for CDC regulations on this topic. In addition, the bill prohibits the CDC from creating a new regulation or policy on controlling the spread of disease that is intended to influence the general public unless the CDC publishes with it evidence supporting the measure, including updated science briefs.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Nov 8, 2023
Introduced in House
Nov 8, 2023
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Rules, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Nov 10, 2023
Referred to the Subcommittee on Health.
  • November 8, 2023
    Introduced in House


  • November 8, 2023
    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Rules, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.


  • November 10, 2023
    Referred to the Subcommittee on Health.

Health

Administrative law and regulatory proceduresCenters for Disease Control and Prevention (CDC)Congressional-executive branch relationsHouse of RepresentativesInfectious and parasitic diseasesLegislative rules and procedureMedical tests and diagnostic methodsSenate

Terminate CDC Overreach Act

USA118th CongressHR-6305| House 
| Updated: 11/10/2023
Terminate CDC Overreach Act This bill narrows the authority of the Centers for Disease Control and Prevention (CDC) to create regulations on controlling the spread of disease. Under current law, the CDC is authorized to create regulations generally relating to quarantine and isolation to prevent the spread of disease between people. This includes regulations applicable to individuals traveling interstate that are reasonably believed to have a disease in a qualifying stage , meaning the disease is contagious or would likely cause a public health emergency if transmitted. The bill specifies that there must be a positive clinical test, rigorous contact tracing, or clinical presentation of the disease in order for individuals to be considered as having a disease in a qualifying stage for purposes of regulation. The bill also specifies that CDC regulations must relate to preventing the spread of disease between states through the identification, isolation, or destruction of the disease itself. The bill establishes procedures for Congress to expedite consideration of joint resolutions of disapproval for CDC regulations on this topic. In addition, the bill prohibits the CDC from creating a new regulation or policy on controlling the spread of disease that is intended to influence the general public unless the CDC publishes with it evidence supporting the measure, including updated science briefs.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Nov 8, 2023
Introduced in House
Nov 8, 2023
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Rules, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Nov 10, 2023
Referred to the Subcommittee on Health.
  • November 8, 2023
    Introduced in House


  • November 8, 2023
    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Rules, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.


  • November 10, 2023
    Referred to the Subcommittee on Health.
Anna Paulina Luna

Anna Paulina Luna

Republican Representative

Florida

Cosponsors (3)
Elijah Crane (Republican)Harriet M. Hageman (Republican)Mary E. Miller (Republican)

Rules Committee, Health Subcommittee, Energy and Commerce Committee

Health

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Administrative law and regulatory proceduresCenters for Disease Control and Prevention (CDC)Congressional-executive branch relationsHouse of RepresentativesInfectious and parasitic diseasesLegislative rules and procedureMedical tests and diagnostic methodsSenate